These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 34352791)
21. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1. Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718 [TBL] [Abstract][Full Text] [Related]
22. LncRNA XIST enhanced TGF-β2 expression by targeting miR-141-3p to promote pancreatic cancer cells invasion. Sun J; Zhang Y Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213574 [TBL] [Abstract][Full Text] [Related]
23. LncRNA-SNHG7 interferes with miR-34a to de-sensitize gastric cancer cells to cisplatin. Pei LJ; Sun PJ; Ma K; Guo YY; Wang LY; Liu FD Cancer Biomark; 2021; 30(1):127-137. PubMed ID: 33074217 [TBL] [Abstract][Full Text] [Related]
24. LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN. Zhang M; Wang F; Xiang Z; Huang T; Zhou WB Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1464-1472. PubMed ID: 32198770 [TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression. Zhang M; Yang H; Chen Z; Hu X; Wu T; Liu W Front Endocrinol (Lausanne); 2021; 12():573143. PubMed ID: 33776905 [TBL] [Abstract][Full Text] [Related]
26. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis. Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127 [TBL] [Abstract][Full Text] [Related]
27. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212 [TBL] [Abstract][Full Text] [Related]
28. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis. Liu X; Xie S; Zhang J; Kang Y Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528 [No Abstract] [Full Text] [Related]
29. Silencing of Long Non-Coding RNA X Inactive Specific Transcript (Xist) Contributes to Suppression of Bronchopulmonary Dysplasia Induced by Hyperoxia in Newborn Mice via microRNA-101-3p and the transforming growth factor-beta 1 (TGF-β1)/Smad3 Axis. Yuan W; Liu X; Zeng L; Liu H; Cai B; Huang Y; Tao X; Mo L; Zhao L; Gao C Med Sci Monit; 2020 Oct; 26():e922424. PubMed ID: 33070148 [TBL] [Abstract][Full Text] [Related]
30. LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1/2 expression. Liu L; Jiang H; Pan H; Zhu X J Int Med Res; 2021 May; 49(5):3000605211016211. PubMed ID: 34018840 [TBL] [Abstract][Full Text] [Related]
31. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. Xu Y; Jiang T; Wu C; Zhang Y Biotechnol Lett; 2020 Jul; 42(7):1123-1135. PubMed ID: 32170433 [TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA X-inactive-specific transcript contributes to cisplatin resistance in gastric cancer by sponging miR-let-7b. Han X; Zhang HB; Li XD; Wang ZA Anticancer Drugs; 2020 Nov; 31(10):1018-1025. PubMed ID: 33009035 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase. Chen Z; Qi L; Fu H; Ma L Bioengineered; 2022 May; 13(5):14013-14027. PubMed ID: 35723009 [TBL] [Abstract][Full Text] [Related]
34. Downregulation of lncRNA X Inactive Specific Transcript (XIST) Suppresses Cell Proliferation and Enhances Radiosensitivity by Upregulating mir-29c in Nasopharyngeal Carcinoma Cells. Han Q; Li L; Liang H; Li Y; Xie J; Wang Z Med Sci Monit; 2017 Oct; 23():4798-4807. PubMed ID: 28985197 [TBL] [Abstract][Full Text] [Related]
35. LncRNA XIST Promotes Migration and Invasion of Papillary Thyroid Cancer Cell by Modulating MiR-101-3p/CLDN1 Axis. Du YL; Liang Y; Cao Y; Liu L; Li J; Shi GQ Biochem Genet; 2021 Apr; 59(2):437-452. PubMed ID: 33057875 [TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA XIST confers aggressive progression via miR-361-3p/STX17 in retinoblastoma cells. Yang LL; Li Q; Zhang X; Cao T Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10433-10444. PubMed ID: 33155266 [TBL] [Abstract][Full Text] [Related]
37. LncRNA XIST promotes human lung adenocarcinoma cells to cisplatin resistance via let-7i/BAG-1 axis. Sun J; Pan LM; Chen LB; Wang Y Cell Cycle; 2017; 16(21):2100-2107. PubMed ID: 28961027 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia induces chemoresistance of esophageal cancer cells to cisplatin through regulating the lncRNA-EMS/miR-758-3p/WTAP axis. Zhu ZJ; Pang Y; Jin G; Zhang HY; Wang WH; Liu JW; Tuo GX; Wu P; Yang Y; Wang ZQ; Wang K Aging (Albany NY); 2021 Jun; 13(13):17155-17176. PubMed ID: 34081626 [TBL] [Abstract][Full Text] [Related]
39. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
40. LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1. Zheng H; Zhang M; Ke X; Deng X; Li D; Wang Q; Yan S; Xue Y; Wang Q Cancer Biomark; 2021; 30(4):395-406. PubMed ID: 33386794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]